Medical AI Startup Selected for JETRO Support Program
It has been announced that a Japanese medical AI startup has been selected for the "J-StarX Medical Data Utilization Program" hosted by the Japan External Trade Organization (JETRO). This program is designed to support the overseas expansion of Japanese startups through the utilization of medical data.
The company selected this time possesses unique technology that combines brain science with AI technology. This technology is characterized by its ability to provide comprehensive support, ranging from disease prevention to diagnostic assistance.
JETRO provides various forms of support to foster Japanese startups that can compete on the global stage. Through this program, the selected company is expected to receive advice from experts and expand its network for entering overseas markets.
The use of AI in the medical field is advancing rapidly around the world. With this selection, attention is focused on how Japanese technology will be utilized in international medical settings and what future developments will emerge.